I very much hope you're right ajk and l do completely understand your rationale however my comments are drawn from past experience with biotechs where good phase 1 results have only resulted in a short term spike in the SP regardless of any compelling evidence such as you have outlined in this instance. Like l said the market is very conservative these days, just look at the reaction to the BV results. Much less than we all predicted beforehand.
Value - a tough one to work out, page-16
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.29M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.6¢ | 1275 | 1 |
View Market Depth
| Last trade - 09.08am 12/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |
Day chart unavailable